Alumis Inc. (ALMS)
NASDAQ: ALMS · Real-Time Price · USD
9.64
-0.71 (-6.86%)
Nov 20, 2024, 4:00 PM EST - Market closed
Alumis Market Cap
Alumis has a market cap or net worth of $524.49 million as of November 21, 2024.
Market Cap
524.49M
Enterprise Value
193.71M
1-Year Change
n/a
Ranking
Category
Stock Price
Market Cap Chart
Since the IPO on June 28, 2024, Alumis's market cap has decreased from $901.92M to $524.49M, a decrease of -41.85%. That is a compound annual growth rate of -74.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 524.49M | -41.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Y-mAbs Therapeutics | 480.14M |
| MeiraGTx Holdings | 475.95M |
| Cartesian Therapeutics | 471.95M |
| GRAIL | 470.41M |
| Perspective Therapeutics | 470.41M |
| Taysha Gene Therapies | 467.27M |
| Theravance Biopharma | 466.66M |
| Acelyrin | 466.51M |